Cargando…
Latest Trends in Outcome Measures in Dementia and Mild Cognitive Impairment Trials
Disease modification trials in dementia and mild cognitive impairment (MCI) have not met with success. One potential criticism of these trials is the lack of sensitive outcome measures. A large number of outcome measures have been employed in dementia and MCI trials. This review aims to describe and...
Autores principales: | Garg, Divyani, Gupta, Anu, Agarwal, Ayush, Mishra, Biswamohan, Srivastava, Madakasira Vasantha Padma, Basheer, Aneesh, Vishnu, Venugopalan Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313078/ https://www.ncbi.nlm.nih.gov/pubmed/35884729 http://dx.doi.org/10.3390/brainsci12070922 |
Ejemplares similares
-
Use of Bacopa monnieri in the Treatment of Dementia Due to Alzheimer Disease: Systematic Review of Randomized Controlled Trials
por: Basheer, Aneesh, et al.
Publicado: (2022) -
Importance of high-quality evidence regarding the use of Bacopa monnieri in dementia
por: Agarwal, Ayush, et al.
Publicado: (2023) -
Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures for Neurological Conditions: Review of Concept and Methods
por: Mishra, Biswamohan, et al.
Publicado: (2023) -
Use of Social Media in Stroke: A Systematic Review
por: Garg, Divyani, et al.
Publicado: (2023) -
Diabetic Amyotrophy (Bruns-Garland Syndrome): A Narrative Review
por: Agarwal, Ayush, et al.
Publicado: (2022)